ÌÇÐÄvlog

Object moved to here.

A Patient With Proteinuria, Myalgias, and Decreased Pigmentation of Facial Skin | Clinical Challenge | JAMA | ÌÇÐÄvlog

ÌÇÐÄvlog

[Skip to Navigation]
Sign In
JAMA Clinical Challenge
July 1, 2024

A Patient With Proteinuria, Myalgias, and Decreased Pigmentation of Facial Skin

Author Affiliations
  • 1Department of Nephrology, Affiliated Suzhou Municipal Hospital of Anhui Medical University, Suzhou, China
  • 2Department of Nephrology, The Fifth Medical Center of PLA General Hospital, Poisoning Treatment Center of PLA, Beijing, China
  • 3Department of Nephrology, The First People’s Hospital of Yongkang, Affiliated to Hangzhou Medical College, Yongkang, China
JAMA. 2024;332(4):329-330. doi:10.1001/jama.2024.6111

A previously healthy woman in her 40s presented with 6 months of bilateral leg edema, insomnia, and myalgias. One month after symptom onset, her creatinine level was 0.80 mg/dL (71 μmol/L) (reference, 0.50-1.19 mg/dL [44-105 μmol/L]) and 24-hour urine protein content was 8.7 g (reference <0.15 g). Kidney biopsy revealed thickening of the glomerular basement membrane with electron-dense deposits, consistent with membranous nephropathy, stage 2. She was treated with 3 days of methylprednisolone (500 mg) and cyclophosphamide (400 mg), followed by prednisolone (1 mg/kg/d) for 8 weeks, subsequently tapered by 10 mg every 4 weeks. Four weeks after initial treatment, proteinuria had decreased to less than 0.5 g/d, but proteinuria increased to 6.72 g/d when the prednisolone dosage was decreased to 20 mg/d.

×